The results from an in vitro study conducted by the University of Texas Medical Branch (UTMB) and Pfizer shows the antibodies from people who have received the Comirnaty COVID-19 vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains.
This study’s findings, published on January 7, 2021, are crucial as rapidly spreading variants of SARS-CoV-2 coronavirus have been reported in various countries, including the United Kingdom and the USA.
Read More
